DIAGNOS Inc.
DGNOF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -39% | -61.2% | 64.3% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -909% | -492.4% | -95.3% | -130.1% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -3,433.7% | -1,437.6% | -478.7% | -916.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -4,129.6% | -1,833.9% | -594.4% | -768.1% |
| EPS Diluted | -0.049 | -0.043 | -0.038 | -0.03 |
| % Growth | -13.3% | -14.4% | -25.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |